Genomic DNA (blood and tumor DNA) from all 30 patients was investigated for LOH using three highly polymorphic microsatellite markers near the NF2 gene region: two flanking markers (D22S268 and D22S275) and one intragenic marker within intron 1 (D22S929). The gene discussed is NF2; the disease is neoplasm.